Causeway Therapeutics
Recent Finacing
Seed
Recent Raise
$1.3M
Causeway Therapeutics is a Glasgow-based biotech developing TenoMiR, a miR29a-replacement therapeutic to restore tendon Type I/III collagen balance for human and equine tendinopathies.
Highlights
Focus Areas
Biopharma
Biotechnology
Health Care
Pharmaceutical
Therapeutics
Recent Investors
Financials
$1.3M
Total Raised
1
Funding round
2
Investors